Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1507827

	registered interest
	date	23/09/2022
	answering body	Women and Equalities
	answering dept id	31
	answering dept short name	Women and Equalities
	answering dept sort name	Women and Equalities
	hansard heading	Women and Equalities: Departmental Responsibilities
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Minister for Women and Equalities, if he will make an assessment of the potential impact of the change in ministerial title from Minister for Women and Equalities to Minister for Equalities on (a) the scope of his ministerial brief, (b) his ministerial objectives and (c) future Government policy.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	55113
	answer	answer is ministerial correction date of answer 12/10/2022 answer text <p>The Minister for Equalities’ role represents all aspects of the women and equalities portfolio in Cabinet. This portfolio has not changed. The Cabinet role will be supported by the Minister for Women and the equalities Lords Minister.</p><p>The regular Women and Equalities Questions session in the Commons also retains that name, to reflect its scope including women’s issues. Details of Ministerial priorities will be shared in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/10/2022 09:32:11 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4124 label Biography information for Chi Onwurah

1507588

	registered interest
	date	22/09/2022
	answering body	Women and Equalities
	answering dept id	31
	answering dept short name	Women and Equalities
	answering dept sort name	Women and Equalities
	hansard heading	Women and Equalities: Cabinet
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Minister for Women and Equalities, what assessment he has made of the implications for his Departments policies of the Minister for Women not attending Cabinet; and if he will make a statement.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	54638
	answer	answer is ministerial correction date of answer 11/10/2022 answer text <p>The Minister for Equalities’ role represents all aspects of the women and equalities portfolio in Cabinet. Gender equality remains part of this portfolio – this was confirmed by the Prime Minister’s spokesperson shortly after the appointment of the Minister for Equalities.</p><p>The Cabinet role will be supported by the Minister for Women and the equalities Lords Minister.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/10/2022 08:51:07 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4657 label Biography information for Anneliese Dodds

1506049

	registered interest
	date	07/09/2022
	answering body	Women and Equalities
	answering dept id	31
	answering dept short name	Women and Equalities
	answering dept sort name	Women and Equalities
	hansard heading	Women and Equalities: Departmental Responsibilities
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Minister for Women and Equalities, what his responsibilities are; and when he plans to populate the responsibilities section of the Minister for Equalities webpage on www.gov.uk which appeared blank when that page was access on 7 September 2022.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	49246
	answer	answer is ministerial correction date of answer 23/09/2022 answer text <p>The equalities brief has not changed and Ministers and officials will continue to be focused on women and equalities issues as before. Gov.uk pages will be updated in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/09/2022 13:04:46 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4657 label Biography information for Anneliese Dodds

1354376

	registered interest
	date	09/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether members of the public who received doses of Astra Zeneca 4120Z001, 4120Z002, 4120Z003 will be entitled to receive a third dose of a vaccination recognised by the European Medicines Agency.
	tabling member constituency	North Durham
	tabling member printed	Mr Kevan Jones
	uin	45808
	answer	answer is ministerial correction date of answer 14/09/2021 answer text <p>Members of the public will not be entitled to receive a third dose of a COVID-19 vaccination on the basis of having received doses of AstraZeneca with batch numbers 4120Z001, 4120Z002, 4120Z003. All AstraZeneca vaccine doses administered in the United Kingdom are the same COVID-19 vaccine and have been authorised for use under Regulation 174, having met the strict standards on safety, quality and efficacy.</p><p>The decision to accept a particular vaccine is ultimately for individual European Union Member States. The EU has published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency for the purposes of travel includes all vaccines administered in the UK, including all batches of AstraZeneca COVID-19 vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/09/2021 15:34:16 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1438 label Biography information for Mr Kevan Jones

1353907

	registered interest
	date	08/09/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	GKN: Birmingham
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential merits of providing grants to support the transition of the GKN Driveline factory in Birmingham to produce components for electric vehicles.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	45102
	answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>The Government has no role in setting the strategic direction or priorities of private sector businesses. As part of the mandatory consultation process on the future of the GKN Driveline factory in Birmingham, the government secured assurances from GKN Automotive that they would consider viable alternatives to closure, including repurposing the plant to produce components for electric vehicles.</p><p> </p><p>Alternative proposals were submitted as part of the consultation. After careful consideration, GKN regrettably concluded there were no viable alternatives to closure.</p><p> </p><p>The government is maintaining a dialogue about the site’s future, actively marketing the site and is working with GKN and local partners to provide support and guidance to the GKN employees. Any potential future commercial propositions for the Birmingham site will be assessed on their own merits.</p><p> </p><p>The Government remains fully committed to working in partnership with industry to support the automotive sector’s transition to zero emission vehicles. Nearly £500m has been made available through the Automotive Transformation Fund to build an internationally competitive electric vehicle supply chain as part of my Rt. Hon. Friend the Prime Minister’s 10 Point Plan. This will create thousands of well-paid green jobs in our industrial heartlands, including the West Midlands.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 15:43:12 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 21087 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	3973 label Biography information for Grahame Morris

1354003

	registered interest
	date	08/09/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Electric Vehicles: Rural Areas
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent assessment he has made of the impact of banning the sale of new petrol and diesel cars by 2030 on people living off the electric grid; and what assessment he has made of the support required by those people living off-grid to assist in the transition to using electric vehicles.
	tabling member constituency	Ceredigion
	tabling member printed	Ben Lake
	uin	45240
	answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>The Government had already committed £1.5 billion to support the early market and remove barriers to zero emission vehicles ownership. Alongside the new phase out dates we have pledged a further £2.8 billion package of measures to support industry and consumers to make the switch to cleaner vehicles.</p><p> </p><p>The Government wants to ensure everyone, including those without access to the electricity grid can still benefit from the transition to zero emission vehicles. The On-Street Residential Chargepoint Scheme (ORCS) is available to all UK local authorities to provide public chargepoints for their residents including those without access to the electricity grid.  Drivers may also chose to charge their vehicle at their workplace, or when they do their shopping.</p><p> </p><p>The forthcoming EV Infrastructure Strategy will also set out Government’s vision for the future of EV charging. A strong focus will be on the needs of those who cannot rely on off-street charging. Local authorities and Chargepoint operators should work together to provide sufficient levels of provision in order to meet demand.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 10:29:07 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 21090 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4630 label Biography information for Ben Lake

1353505

	registered interest
	date	07/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has for a covid-19 vaccine booster campaign in autumn 2021.
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	uin	44364
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021, which can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI’s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine, and flu vaccine, as soon as possible from September, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster programme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply and approvals by the Medicines and Healthcare products Regulatory Agency.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:46:11 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4385 label Biography information for Dr Philippa Whitford

1353507

	registered interest
	date	07/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long term monitoring of immunity in people who have received different covid-19 vaccines for each dose.
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	uin	44365
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose.</p><p>Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The antibody results will be published in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 09:07:39 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4385 label Biography information for Dr Philippa Whitford

1353563

	registered interest
	date	07/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus Certificates: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 July 2021 to Question 31551, when UK residents vaccinated against covid-19 while overseas with a (a) Pfizer, (b) Oxford-AstraZeneca and (c) Moderna vaccine are able to be certified as vaccinated by the UK.
	tabling member constituency	North East Bedfordshire
	tabling member printed	Richard Fuller
	uin	44282
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>Work is underway to determine which non-Medicines and Healthcare products Regulatory Agency authorised vaccines we will recognise with confidence to enable United Kingdom residents vaccinated abroad to demonstrate their vaccination status. A solution will be rolled out in England as a pilot from the end of September.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 16:36:09 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	3912 label Biography information for Richard Fuller

1353571

	registered interest
	date	07/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Care Homes: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the policy that staff at CQC-registered care homes must have received both covid-19 doses from 11 November 2021 on staffing levels in those homes.
	tabling member constituency	Richmond Park
	tabling member printed	Sarah Olney
	uin	44423
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The Department has published an impact statement detailing the expected effect of the vaccination as a condition of deployment policy on care homes. The department will publish a full impact assessment in due course. We continue to monitor the impact of the policy on care homes as we approach 11 November.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:48:13 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4591 label Biography information for Sarah Olney

1353594

	registered interest
	date	07/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pregnancy: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the risk covid-19 poses to unvaccinated pregnant women; and what steps he is taking to ensure pregnant women receive both doses of the vaccine before their third trimester.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	44411
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>Although the overall risk from COVID-19 in pregnant women is low, in later pregnancy some women may become seriously unwell and need hospital treatment. Pregnant women with COVID-19 have a higher risk of intensive care admission than women of the same age who are not pregnant. Women with COVID-19 disease are also 2-3 times more likely to have their babies early than women without COVID-19. Pregnant women with underlying clinical conditions are at even higher risk of suffering serious complications from COVID-19.</p><p> </p><p>Currently, the Joint Committee on Vaccination and Immunisation (JCVI) recommends an interval of 8 weeks between doses of all the available COVID-19 vaccines; this includes pregnant women. It is important to note that current evidence shows that a longer dose interval produces a better immune response. The JCVI regularly reviews its advice in relation to COVID-19 Vaccination Programme, taking into account new data and evidence on the effectiveness of the programme and epidemiological situation.</p><p> </p><p>We are working hard to drive uptake in pregnant women, to ensure that as many pregnant women take up the offer of vaccination as soon as possible so that they are protected throughout their pregnancy. It is understood that pregnant women may prefer to wait to be vaccinated until after they have given birth. It is important for pregnant women to discuss their offer of vaccination with a healthcare professional in relation to the risks and benefits of the vaccine.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:44:02 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4510 label Biography information for Helen Hayes

1353595

	registered interest
	date	07/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pregnancy: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of bringing forward pregnant women's second doses of the covid-19 vaccine before their third trimester.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	44412
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>Currently, the Joint Committee on Vaccination and Immunisation (JCVI) recommends an interval of eight weeks between doses of all the available COVID-19 vaccines; this includes pregnant women. On 14 May 2021, in response to the increasing rates of infection of the Delta variant, the Government amended the interval of second doses for the most vulnerable cohorts who were offered a vaccine in phase one of the programme, from 12 weeks to an eight-week gap. The eight-week dose interval was applied to all eligible cohorts from 6 July.</p><p>It should be noted that current evidence shows that a longer dose interval produces a better immune response. As such, the JCVI has advised against reducing the dose interval further in order to maximise the effectiveness of the vaccination programme. The JCVI regularly reviews its advice in relation to COVID-19 vaccinations, taking into account new data and evidence on the effectiveness of the programme and the ongoing epidemiological situation<em>.</em></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 10:26:14 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4510 label Biography information for Helen Hayes

1352871

	registered interest
	date	06/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many covid-19 vaccines have been disposed of that were (a) out of date (b) unused to date.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	43653
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The information requested is not currently centrally held. Work is ongoing across the vaccination programme to standardise and increase the information available for management purposes.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 11:00:27 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1352957

	registered interest
	date	06/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what evidence his Department holds on the potential benefits of immunisation against covid-19 for people who have previously tested positive for that virus.
	tabling member constituency	Kingston upon Hull West and Hessle
	tabling member printed	Emma Hardy
	uin	43644
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>It is not known how long antibodies made in response to natural COVID-19 infection persist, and whether immunisation could offer more protection. However, it is expected the COVID-19 vaccine would boost any pre-existing antibodies from previous infection. There is no evidence of any safety concerns from vaccinating individuals with a history of COVID-19 infection or with detectable antibodies to COVID-19. Therefore, people who have had COVID-19 disease – whether confirmed or suspected – should still receive the COVID-19 vaccine.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 09:12:09 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4645 label Biography information for Emma Hardy

1353027

	registered interest
	date	06/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the data and evidential basis which supports the decision of the Joint Committee on Vaccination and Immunisation to authorise administration of a covid-19 vaccine to people aged 16 and 17.
	tabling member constituency	Gateshead
	tabling member printed	Ian Mearns
	uin	43491
	answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s advice on vaccination of those aged 16 to 17 years old was published on 4 August 2021. The statement sets out the basis for the advice and includes references to supporting evidence and is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years" target="_blank">https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 16:39:03 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4000 label Biography information for Ian Mearns

1353036

	registered interest
	date	06/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Covid Pass
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with relevant stakeholders to help ensure that people who received doses of the AstraZeneca covid-19 vaccine produced in India are able to demonstrate their vaccination status when travelling overseas.
	tabling member constituency	Rotherham
	tabling member printed	Sarah Champion
	uin	43526
	answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government continues to liaise with international partners and other organisations, such as the International Civil Aviation Organization and the World Health Organization, to support the work on certification to ensure that global travel is unhindered and supported by a common approach.</p><p>All doses of AstraZeneca COVID-19 vaccines manufactured in India and administered in the United Kingdom are the same product, under the same authorisation as all other AstraZeneca vaccine doses deployed in the UK, now known commercially Vaxzevria. They appear on the NHS COVID Pass as such, which has been available for international travel since May. Decisions on which vaccines countries will accept at their borders are for respective Governments and we continue to actively engage with these countries to ensure all AstraZeneca doses administered in the UK, including those manufactured in India, are recognised.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 16:41:39 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4267 label Biography information for Sarah Champion

1353044

	registered interest
	date	06/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of prison inmates have been (a) offered a covid-19 vaccine and (b) vaccinated against covid-19.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	43638
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>All eligible prisoners in England have been offered a COVID-19 vaccine and according to the latest available data, 44% are now fully vaccinated with two doses. This includes 80% of those over 50 years old and 37% of the under 50 year old population.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 16:30:50 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4620 label Biography information for Ellie Reeves

1352198

	registered interest
	date	03/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether people who normally receive a flu vaccination, including people with asthma and lung conditions, will receive a covid-19 booster vaccination in autumn 2021.
	tabling member constituency	Leeds Central
	tabling member printed	Hilary Benn
	uin	41664
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccinations should first be offered to the most vulnerable. The JCVI advises a two stage approach, with individuals in stage one offered a booster vaccine and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests those aged 16 to 49 years old who are in an influenza or COVID-19 at risk group, including some patients with chronic respiratory disease and asthma are currently included in stage two.</p><p>Final decisions on the timing and scope and cohort eligibility, booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 42174 question first answered 08/09/2021 15:14:12 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	413 label Biography information for Hilary Benn

1352226

	registered interest
	date	03/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether coeliac disease is an eligible condition for children to receive the covid-19 vaccination; and what steps his Department is taking to ensure that children's eligibility for that vaccination is decided consistently across GP practices.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	41854
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation advises that asplenia or dysfunction of the spleen constitutes a risk group for the purpose of COVID-19 vaccination of children. Hyposplenism or reduced spleen function in coeliac disease is uncommon in children and the prevalence correlates with the duration of exposure to gluten. Therefore, children diagnosed with coeliac disease early in life whose condition is well managed are unlikely to require vaccination.</p><p>Clinical judgment should be applied in identifying these children on a case by case basis.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 09:17:38 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4079 label Biography information for Julian Sturdy

1352269

	registered interest
	date	03/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people have died within 28 days of receiving the covid-19 vaccination in England.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	41912
	answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>The data requested is not held by the Department.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 13:14:39 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4418 label Biography information for Justin Madders

1352409

	registered interest
	date	03/09/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Life Sciences: Devolved Matters
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps the Government is taking to work with the devolved nations in respect of the delivery of its Life Sciences Vision.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	42009
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The Life Sciences Vision is UK-wide and aims to increase the health, wealth and resilience for all four nations of the United Kingdom. The Government worked closely with the devolved administrations and stakeholders from all parts of the UK in developing the Vision, to ensure that it reflected the strengths and opportunities of the whole UK.</p><p> </p><p>We will continue to work closely with the devolved administrations as we implement the Vision. BEIS officials are in regular contact with their devolved counterparts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 12:59:23 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4488 label Biography information for Martyn Day

1352517

	registered interest
	date	03/09/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many doses of covid-19 vaccine the UK has received from Covax for each month since Covax has been in operation; for what reasons the UK has received doses through Covax; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	41806
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The UK committed approximately £71 million to the self-financing facility of COVAX, which enables high and upper-middle income countries to pool investments in potential vaccine candidates, and supported its establishment last year. This gives us the option to buy vaccines for up to 20% of the UK population - approximately 27 million doses. The Government has separately committed £548 million to the COVAX Advance Market Commitment, which will distribute 1.2 billion doses of vaccines to developing countries this year.</p><p> </p><p>In addition, I am proud that as part of our commitment to the G7 to donate 100m doses over the course of the next year, the UK has so far donated over 10 million doses to those countries most in need, of which over 6 million have gone to COVAX. Throughout the COVID-19 vaccination programme, vaccine supply and deliveries have been carefully managed by the Vaccine Taskforce to meet the requirements of the domestic vaccination programme as well as support other countries’ domestic campaigns. The recent sharing of 4 million doses with Australia is a good example of this.</p><p> </p><p>I refer the Hon. Member to the answer I gave her on 3rd March 2021 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2021-02-23/157070" target="_blank">157070</a>: the UK procured approximately 0.5 million doses of the Pfizer vaccine through COVAX, which were delivered earlier this year. These doses helped the NHS deliver our vaccination programme as quickly as possible. No further doses have been received by the UK from COVAX.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 13:04:33 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	3930 label Biography information for Caroline Lucas

1352544

	registered interest
	date	03/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the findings of (a) the ONS that chronic lower respiratory disease is the third most common underlying condition with death as a result of covid-19 in quarter 2 of 2021 and (b) of the British Lung Foundation, in its 2012 survey, that 81 per cent of chronic lower respiratory disease is asthma, if he will make it his policy that people with asthma who receive a free annual flu vaccination will be included in any covid-19 booster vaccination programme.
	tabling member constituency	North Norfolk
	tabling member printed	Duncan Baker
	uin	42174
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccinations should first be offered to the most vulnerable. The JCVI advises a two stage approach, with individuals in stage one offered a booster vaccine and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests those aged 16 to 49 years old who are in an influenza or COVID-19 at risk group, including some patients with chronic respiratory disease and asthma are currently included in stage two.</p><p>Final decisions on the timing and scope and cohort eligibility, booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41664 question first answered 08/09/2021 15:14:11 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4784 label Biography information for Duncan Baker

1352594

	registered interest
	date	03/09/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Biofuels: Production
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to promote ethanol production in the UK.
	tabling member constituency	Wokingham
	tabling member printed	John Redwood
	uin	41600
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The UK biofuel market, including bioethanol, has been supported since 2008 through the Renewable Transport Fuel Obligation (RTFO). The RTFO is a certificate trading scheme which sets targets and provides financial incentives for the supply of sustainable biofuels. This month the government has introduced E10 as the standard petrol across Great Britain. The introduction of E10 increases the amount of bioethanol blended with petrol sold at forecourts in the UK. E10’s introduction has been welcomed by the UK bioethanol industry as positive for the environment and jobs in UK production plants and supply chain.</p><p> </p><p>More broadly, the chemicals sector is crucial to the UK; with 83% of employment outside of London and the South East it provides high-skilled, highly paid jobs across the UK and supplies essential inputs to almost all other manufacturing industries.</p><p> </p><p>Last year's UK Budget sets out our ambition to spread opportunity across the UK, led by vital investment, to help important businesses such as chemical companies to grow, and improve access to skills, capital and ideas. This ambition is being supported by measures such as the new two-year super-deduction that will cut companies’ tax bill by 25p for every pound they invest in new equipment and mean they can reduce their taxable profits by 130% of the cost. In addition, the Government has a target for total R&amp;D investment to reach 2.4% of GDP by 2027 and in the recent Innovation strategy we have committed to increase our annual public investment in R&amp;D to a record £22billion.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 15:22:11 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	14 label Biography information for Sir John Redwood

1352693

	registered interest
	date	03/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to provide similar guidance to the temporary clinical authorisation granted by the Medicine and Healthcare Products Regulatory Agency (MHRA) to the Pfizer/BioNtech vaccine on 2 December 2020, to the MHRA in regards to the fast-tracking of nasal covid-19 vaccines; and if he will make a statement.
	tabling member constituency	Broxbourne
	tabling member printed	Sir Charles Walker
	uin	41742
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>COVID-19 vaccines which can be administered nasally are currently in early clinical trials. Any route to approval of such treatments will be subject to the developer seeking regulatory approval from the United Kingdom’s independent medicines regulator, the Medicines and Healthcare products Regulatory Agency.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 13:59:54 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1493 label Biography information for Sir Charles Walker

1350856

	registered interest
	date	18/08/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	New Businesses: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support start-ups in the manufacturing sector.
	tabling member constituency	Wolverhampton South West
	tabling member printed	Stuart Anderson
	uin	41272
	answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government is committed to supporting UK manufacturing businesses, including start-ups and recognises the vital role they play in the UK economy, by driving innovation, exports, job creation and productivity growth.</p><p> </p><p>We are committed to supporting manufacturers to take advantage of innovative technology and we recently announced <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2F8-million-government-boost-for-manufacturers-across-england-to-go-digital&amp;data=04%7C01%7Cfilder.onek%40beis.gov.uk%7Caa8df0a9fa1b47253ef508d966631201%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637653397946777930%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JbjtVD2pKuArzY4hKwXd7ZbWr5lCJDL85VcFmQvt5pw%3D&amp;reserved=0" target="_blank">£8 million in new government funding for the Made Smarter Adoption programme to help Small and Medium Sized Enterprises (SMEs</a>) increase productivity, competitiveness and drive up efficiency by adopting industrial digital technology, building on the success of our Made Smarter North West Pilot.</p><p> </p><p>The Government’s business support schemes have been put in place to help eligible businesses to get through the pandemic, from all regions and backgrounds. Information on these schemes and other resources is available via the free Business Support Helpline.</p><p> </p><p>The Start Up Loans Company, part of the Government-owned British Business Bank, provides loans and pre- and post-application support to new entrepreneurs, including a year of free business mentoring for successful applicants. Since 2012, over 86,000 Start Up Loans worth over £769 million have been issued to new entrepreneurs. We are also investing £147 million through the Made Smarter Innovation programme to help forward-thinking UK manufacturers create new, green products and processes, slash carbon emissions, drive up productivity and create thousands of highly skilled new jobs across the country.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 12:39:38 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4742 label Biography information for Stuart Anderson

1350957

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce covid-19 vaccine wastage; and what action is taken with unused vaccines.
	tabling member constituency	Birmingham, Ladywood
	tabling member printed	Shabana Mahmood
	uin	40820
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No vaccines should be wasted. All vaccination centres should have a backup list of people in the cohorts currently being vaccinated, who can be called in case doses would be wasted. This is in line with the Enhanced Service Specification for the COVID-19 vaccination programme 2020/21.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction, including, where there is data to support it, looking at the extension of expiry dates.</p><p>The United Kingdom is also one of the largest donors to COVID-19 Vaccines Global Access (COVAX). We will donate at least 100 million surplus doses within the next year, with the first batch of five million already delivered last month.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:43:56 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	3914 label Biography information for Shabana Mahmood

1350995

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Travel: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people who have received two covid-19 vaccinations, including Oxford AstraZeneca batch numbers (a) 4120Z001, (b) 4120Z002 and (c) 4120Z003, are able to travel to EU countries.
	tabling member constituency	Halifax
	tabling member printed	Holly Lynch
	uin	41025
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The European Union has recently published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency, for travel purposes which is at the following link:</p><p> </p><p><a href="https://reopen.europa.eu/en" target="_blank">https://reopen.europa.eu/en</a></p><p> </p><p>The list includes all vaccines administered in the United Kingdom, including all batches of AstraZeneca vaccine administered in the UK known commercially as Vaxzevria. This also includes batches 4120Z001, 4120Z002 and 4120Z003. Decisions on which vaccines EU Member States will accept at their borders is for those countries to decide. We are not aware that any have decided not to accept UK vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:15:23 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4472 label Biography information for Holly Lynch

1351014

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Travel: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with its counterpart in Italy in respect of British tourists' entry to Italy whose covid-19 vaccine was manufactured at Serum Institute in India.
	tabling member constituency	Meriden
	tabling member printed	Saqib Bhatti
	uin	41357
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield vaccines and both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the United Kingdom (UK) regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’.</p><p> </p><p>The government continues to liaise with counterparts in Italy and we are seeking Italian confirmation that they will recognise all AstraZeneca doses administered in the UK. We will ensure that Foreign, Commonwealth and Development Office Travel Advice is kept up to date following any developments.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:10:14 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4818 label Biography information for Saqib Bhatti

1351023

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Travel: Quarantine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason Government policy makes a distinction between covid-19 vaccines received in the UK and those received overseas when deciding whether a traveller returning from an amber list country needs to quarantine.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Luke Pollard
	uin	41240
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Government is currently undertaking extensive work to consider which regulators and associated vaccines we would recognise. It is important to consider which regulators have similar stringent standards of authorisation as the Medicines Healthcare products Regulatory Agency, which has some of the highest standards of quality, safety and efficacy in the world. This will then feed into discussions regarding quarantine from amber-listed countries.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:22:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4682 label Biography information for Luke Pollard

1351024

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether there is a material difference in terms of (a) medical and (b) public health effect between covid-19 vaccines administered overseas and those administered domestically by the NHS.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Luke Pollard
	uin	41241
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>Comparisons between vaccines administered across the world are complex due to differences in vaccine trials and monitoring. When a vaccine receives a marketing authorisation or conditional marketing authorisation from a medicines regulator, certain factors or conditions are specified by the national regulator in order to ensure the product is of the highest quality, safety and efficacy for authorisation.</p><p>We are currently considering which regulators and associated vaccines we would be confident to recognise in the United Kingdom.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:06:24 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4682 label Biography information for Luke Pollard

1351044

	registered interest
	date	18/08/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Vans: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent assessment he has made of vehicle supply shortages affecting the UK van sector; and what cross-departmental steps he is taking to help rectify those supply shortages.
	tabling member constituency	Ealing Central and Acton
	tabling member printed	Dr Rupa Huq
	uin	41074
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The Government has regularly engaged with multiple stakeholders including the Department for Transport, manufacturers and automotive trade associations to discuss steps to help rectify supply chain shortages.</p><p> </p><p>The Government recognises the severity of the semiconductor shortage and its impacts on vehicle supply chains. BEIS officials are working with the Department for Digital, Culture, Media and Sport (DCMS) who are leading on this issue. DCMS is working closely with companies affected by this shortage to discuss interim support measures and supply solutions, as well as lobbying for a coordinated multilateral response through the G7. DCMS is also engaging bilaterally with key supplier countries like the US and Japan, to lobby for fair UK access to currently constrained supply and address systemic issues in the sector to avoid future repetition of the current shortage.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 12:56:58 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4511 label Biography information for Dr Rupa Huq

1351056

	registered interest
	date	18/08/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Motor Vehicles: Waste Disposal
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has made an assessment of the potential merits of introducing a dedicated scrapping system for diesel and petrol vehicles ahead of the transition towards zero emission vehicles by 2030.
	tabling member constituency	Coventry South
	tabling member printed	Zarah Sultana
	uin	41316
	answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government is investing £2.8 billion to support the transition to zero emission vehicles, including to support the uptake of zero and ultra low emission cars, vans, trucks, motorcycles, taxis and buses, as well funding to support charge point infrastructure at homes, workplaces, on residential streets and across the wider roads network, to make charging as easy as refuelling a petrol or diesel car.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 13:11:15 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4786 label Biography information for Zarah Sultana

1351060

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NHS England plans to use the flu vaccine list to prioritise patients, including those with asthma, for the covid-19 booster vaccination.
	tabling member constituency	Leeds Central
	tabling member printed	Hilary Benn
	uin	40603
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021 which can be found at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022</a></p><p> </p><p>The JCVI’s interim advice is that COVID-19 boosters are first offered to the most vulnerable. They advise a two-staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine as well as a flu vaccine, as soon as possible from September 2021, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible. Adults aged over 50 years old, and those aged between 16 and 49 who are in an influenza or COVID-19 at-risk group, are included in Stage 2.</p><p>It is important to note that the JCVI’s advice is interim to inform planning, and this may be subject to change.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:45:22 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	413 label Biography information for Hilary Benn

1351082

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the effect of the expansion of eligibility for flu vaccination to the over 50s in (a) 2020-21 and (b) 2021-22.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	40611
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40613 40614 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	429 label Biography information for Derek Twigg

1351083

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what criteria his Department will use to determine whether the temporary expansion of eligibility for flu vaccination to people aged over 50 should be made permanent.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	40612
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>Advice from the Joint Committee on Vaccination and Immunisation (JCVI) noted that it was advisable to continue the vaccination of the 50–64-year-old cohort because from the age of 50 years old, individuals are at a greater risk of being hospitalised as a result of COVID-19 and the result of coinfection of COVID-19 and flu is likely to be more severe. However, no decision has been made on whether the eligibility of this cohort will be made permanent.</p><p>The Department will continue to consider the advice of the JCVI in decisions on which flu cohorts are recommended for a flu vaccine in the future. The JCVI use the National Institute for Health and Care Excellence’s methodology and criteria to assess whether a vaccine programme can be considered cost effective or not.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 15:02:32 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18931 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	429 label Biography information for Derek Twigg

1351084

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to improve uptake of the flu vaccination among people aged between 50 and 64 in 2021-22.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	40613
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40611 40614 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	429 label Biography information for Derek Twigg

1351085

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department (a) has taken and (b) plans to take to improve the uptake of the flu vaccine among people aged 50 to 64 in 2021-22.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	40614
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40611 40613 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	429 label Biography information for Derek Twigg

1351210

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus Certificates
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he taking to help ensure that people who are advised not to have the covid-19 vaccination for clinical reasons are not disadvantaged by the Government's proposals for use of covid-19 certificates.
	tabling member constituency	Chipping Barnet
	tabling member printed	Theresa Villiers
	uin	40730
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p><strong> </strong></p><p>Any venue that adopts COVID-19 status checks as a condition of entry must comply with the relevant legal obligations such as the Equalities Act 2010 when deciding whether or not to accept medical exemptions.</p><p>Senior clinicians are currently drafting clinical guidance which will include and apply to conditions such as multiple sclerosis and other disabilities.</p><p>We will set out our plans shortly for a clinical review of medical exemptions which will enable individuals to show their COVID-19 status using the NHS COVID Pass.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41252 question first answered 07/09/2021 15:19:53 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1500 label Biography information for Theresa Villiers

1351233

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the risk that routine requests by NHS vaccination centres for NHS and National Insurance numbers may make people who are in the UK illegally less likely to engage with the covid-19 vaccination programme.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	40751
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No such assessment has been made.</p><p>However, a National Health Service (NHS) number or national insurance number is not needed to make a booking for a COVID-19 vaccine or when attending a vaccination appointment.</p><p>As vaccination against COVID-19 is offered to every eligible adult living in the United Kingdom free of charge, regardless of their immigration status. No immigration checks are needed to receive a COVID-19 vaccination and the NHS is not required to report undocumented migrants to the Home Office.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:45:41 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1522 label Biography information for Adam Holloway

1351267

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department have taken steps to enable people who participated in the Novavax covid-19 vaccine trials to travel internationally; and what support his Department has provided to the European Medicines Agency for the registration of that vaccine.
	tabling member constituency	Henley
	tabling member printed	John Howell
	uin	40817
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Government continues to make the case that anyone on a COVID-19 vaccine trial should be treated the same in terms of certification as someone who has received a deployed vaccine. Our Chief Medical Officer has written to all of his counterparts in the European Union and European Economic Community on this matter. Discussions are ongoing with other countries, including through groups such as the Group of Seven, the European Commission and the World Health Organisation to shape the approach taken around the world to sharing health status for travel.</p><p>The Vaccines Taskforce and the Medicines and Healthcare products Regulatory Agency (MHRA) are working with Novavax to help ensure their COVID-19 vaccine is authorised as quickly as possible. The decision to license a vaccine is made by the MHRA.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41230 question first answered 06/09/2021 11:43:29 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1606 label Biography information for John Howell

1351274

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Joint Committee on Vaccination and Immunisation's (JCVI) recommendation of 4 August 2021 that covid-19 vaccinations should be extended to 16 to 17-year-olds, if he will publish a detailed briefing on the material changes that were provided by the JCVI from their position set out in the JCVI statement on COVID-19 vaccination of children and young people aged 12 to 17 years: 15 July 2021, published on 19 July 2021, that stated that the benefits of universal vaccination in children and young people below the age of 18 do not outweigh the potential risks.
	tabling member constituency	Tynemouth
	tabling member printed	Sir Alan Campbell
	uin	40616
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The minutes of the Joint Committee on Vaccination and Immunisation's (JCVI) meetings in which the COVID-19 vaccination of children and young people were discussed, including those between 15 July and 04 August 2021, will be published on GOV.UK in due course. Any additional briefing will not be published.</p><p>Minutes of the JCVI meetings can be found at the following link:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation#minutes" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation#minutes</a>.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 12:11:41 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	529 label Biography information for Sir Alan Campbell

1351320

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with his EU counterpart on accepting the Novavax covid-19 vaccine for international travel.
	tabling member constituency	Battersea
	tabling member printed	Marsha De Cordova
	uin	41230
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Government continues to make the case that anyone on a COVID-19 vaccine trial should be treated the same in terms of certification as someone who has received a deployed vaccine. Our Chief Medical Officer has written to all of his counterparts in the European Union and European Economic Community on this matter. Discussions are ongoing with other countries, including through groups such as the Group of Seven, the European Commission and the World Health Organisation to shape the approach taken around the world to sharing health status for travel.</p><p>The Vaccines Taskforce and the Medicines and Healthcare products Regulatory Agency (MHRA) are working with Novavax to help ensure their COVID-19 vaccine is authorised as quickly as possible. The decision to license a vaccine is made by the MHRA.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40817 question first answered 06/09/2021 11:43:29 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4676 label Biography information for Marsha De Cordova

1351323

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what criteria he plans to use to determine (a) whether to implement a booster covid-19 vaccination programme in autumn 2021 and (b) which population groups that programme should cover.
	tabling member constituency	Forest of Dean
	tabling member printed	Mr Mark Harper
	uin	40741
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30th June 2021 which can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI’s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two-staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine as well as a flu vaccine, as soon as possible from September 2021 and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>It is important to note that this is interim advice to inform planning and this advice may be subject to change before being finalised. Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster programme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:43:13 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1520 label Biography information for Mr Mark Harper

1351354

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for people who have (a) multiple sclerosis and (b) other disabilities preventing them from receiving the covid-19 vaccine of the use of vaccine passports which may be mandatory for some activities.
	tabling member constituency	Lewisham East
	tabling member printed	Janet Daby
	uin	41252
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p><strong> </strong></p><p>Any venue that adopts COVID-19 status checks as a condition of entry must comply with the relevant legal obligations such as the Equalities Act 2010 when deciding whether or not to accept medical exemptions.</p><p>Senior clinicians are currently drafting clinical guidance which will include and apply to conditions such as multiple sclerosis and other disabilities.</p><p>We will set out our plans shortly for a clinical review of medical exemptions which will enable individuals to show their COVID-19 status using the NHS COVID Pass.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40730 question first answered 07/09/2021 15:19:53 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4698 label Biography information for Janet Daby

1351444

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the viability of a covid-19 booster jab for vulnerable groups who were vaccinated earlier in 2021 ahead of winter 2021-22.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Paula Barker
	uin	41373
	answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccines should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in stage one offered a COVID-19 booster and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing, scope and eligibility will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 14:44:41 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4828 label Biography information for Paula Barker

1351446

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of extending the free flu vaccination programme to teachers in (a) primary and (b) secondary schools.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	40722
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Teachers and other key workers, aside from frontline health and care staff, who are not in an at-risk group are not eligible for a free flu vaccination in England. However, they may have access to the flu vaccine under their employers’ occupational health scheme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:50:23 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1447 label Biography information for Andrew Rosindell

1351532

	registered interest
	date	18/08/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Honda: Swindon
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the effect of the closure of the Honda plant in Swindon on levels of employment in that area.
	tabling member constituency	Newport West
	tabling member printed	Ruth Jones
	uin	41270
	answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>Following Honda’s announcement in February 2019 that it would close its Swindon plant in 2021, the company has worked closely with Government, Local Authorities and other stakeholders to support affected employees. The Government-led Honda Taskforce was instrumental in securing a new future for the Swindon site and attracting investment into Swindon, including over £44 million to regenerate the town centre. The sale of the site to Panattoni that Honda announced on 26 March represents £400million of private investment for the region and will create around 2,000 new jobs.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 12:53:40 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4716 label Biography information for Ruth Jones

1351584

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people with a phobia of needles will be made aware of when a version of a covid-19 vaccine which does not require needles is approved for use.
	tabling member constituency	Morley and Outwood
	tabling member printed	Andrea Jenkyns
	uin	41045
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Department will ensure that a comprehensive announcement is made if a COVID-19 vaccine that can be delivered without the use of a needle is approved.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency continues to monitor and engage with developers and producers of both currently approved and new COVID-19 vaccines and offers scientific advice on new technical developments. We are unable to comment on products that are not approved for use in the United Kingdom due to commercial and market sensitivities surrounding the approval processes.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:44:12 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4490 label Biography information for Dame Andrea Jenkyns

1351635

	registered interest
	date	18/08/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Electric Vehicles: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps is he taking to encourage the purchase of fleets of e-vans from British manufacturers.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	40587
	answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government has provided over £100m in funding through the Plug-in Van Grant (PIVG) since its launch in 2012, supporting the purchase of over 15,000 ultra-low emission vans and trucks, the majority of which are zero emission vehicles. Demand for zero emission vans rose substantially in 2020, with increased interest from commercial fleets, and we expect this trend to continue as more models are brought to market and supply increases.</p><p> </p><p>More widely, the Government welcomes action to accelerate the development of British made electric vehicles and an announcement from the Electric Vehicle Fleet Accelerator Group, made up of seven major UK companies who have pledged to buy 70,000 British made electric vans by 2030. As part of the 10 Point Plan for a green industrial revolution, nearly £500 million of funding for the Automotive Transformation Fund will be made available in the next four years to invest in capital and R&amp;D projects to build an internationally competitive electric vehicle supply chain. This funding is the first part of the up to £1 billion committed by the Government to ensure that the UK takes advantage of this once in a generation opportunity.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 12:32:16 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	318 label Biography information for John Spellar